DuoGenic StemCells (ROCO:7607) OCF Margin %: -95.70% (As of Dec. 2025)


ROCO:7607 DuoGenic StemCells Corp ROCO:7607
25 GF Score
Price NT$13.75
GF Value NT$50.56
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is DuoGenic StemCells OCF Margin %?

DuoGenic StemCells ROCO:7607 -2.48% 25 OCF Margin % is -95.70% as of Dec. 2025. GuruFocus rates ROCO:7607 with a GF Score™ of 25/100 and a GF Value™ of NT$50.56 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, DuoGenic StemCells ranks worse than 52.76% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. DuoGenic StemCells's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$-9.85 Mil. DuoGenic StemCells's Revenue for the six months ended in Dec. 2025 was NT$10.29 Mil. Therefore, DuoGenic StemCells's OCF Margin % for the quarter that ended in Dec. 2025 was -95.70%.

As of today, DuoGenic StemCells's current OCF Yield % is -3.63%.

The historical rank and industry rank for DuoGenic StemCells's OCF Margin % or its related term are showing as below:

ROCO:7607' s OCF Margin % Range Over the Past 10 Years
Min: -870.31   Med: -392.7   Max: -89.28
Current: -89.28

During the past 5 years, the highest OCF Margin % of DuoGenic StemCells was -89.28%. The lowest was -870.31%. And the median was -392.70%.

ROCO:7607's OCF Margin % is ranked worse than
52.76% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ROCO:7607: -89.28

DuoGenic StemCells OCF Margin % Related Terms

DuoGenic StemCells OCF Margin % Historical Data

* Premium members only.

The historical data trend for DuoGenic StemCells's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DuoGenic StemCells OCF Margin % Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
-870.31 -486.10 -319.46 -392.70 -89.28

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only -336.45 -485.21 -325.01 -82.92 -95.70

ROCO:7607 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, DuoGenic StemCells's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuoGenic StemCells OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DuoGenic StemCells's OCF Margin % distribution charts can be found below:

* The bar in red indicates where DuoGenic StemCells's OCF Margin % falls into.


ROCO:7607
25GF Score
DuoGenic StemCells Corp ROCO:7607
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DuoGenic StemCells OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

DuoGenic StemCells's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-18.474/20.693
=-89.28 %

DuoGenic StemCells's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-9.847/10.289
=-95.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -95.70% mean?
DuoGenic StemCells (ROCO:7607) has a OCF Margin % of -95.70% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on DuoGenic StemCells and its competitors. According to the industry distribution chart, DuoGenic StemCells ranks #506 out of 959 companies in the Biotechnology industry, placing it in the top 52.8%.
Is DuoGenic StemCells' OCF Margin % too high?
DuoGenic StemCells' current OCF Margin % is -95.70%. Based on the distribution chart, DuoGenic StemCells ranks #506 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, DuoGenic StemCells has a GF Score™ of 25/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DuoGenic StemCells' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, DuoGenic StemCells ranks #506 out of 959 companies for OCF Margin %. This places DuoGenic StemCells in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on DuoGenic StemCells and its competitors. DuoGenic StemCells's current OCF Margin % is -95.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DuoGenic StemCells stock overvalued right now?
Based on GuruFocus' analysis, DuoGenic StemCells (ROCO:7607) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$50.56, compared to a current price of NT$13.75 — trading 72.8% below its estimated fair value. The current OCF Margin % is -95.70%. DuoGenic StemCells' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For DuoGenic StemCells (ROCO:7607), the current OCF Margin % is -95.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DuoGenic StemCells (ROCO:7607) Overvalued in 2026?

Based on GuruFocus' analysis, DuoGenic StemCells stock appears to be undervalued. The current stock price of NT$13.75 is trading 72.8% below its estimated GF Value™ of NT$50.56. GuruFocus considers DuoGenic StemCells to be Significantly Undervalued.

Key valuation signals for ROCO:7607:

  • OCF Margin %: -95.70%
  • GF Value™: NT$50.56 vs. price of NT$13.75 (72.8% below fair value)
  • GF Score™: 25/100 with 2 warning signs

No single metric tells the full story. See the ROCO:7607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DuoGenic StemCells Business Description

Address Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.
25GF Score

Get the complete analysis for ROCO:7607

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.75
Price
NT$50.56
GF Value